PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT05896774
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 270
- Registration Number
- NCT05895786
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai, Shanghai, China
🇨🇳West China Hospital, Sichuan University, Cheng Du, Sichuan, China
A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT05891600
- Locations
- 🇨🇴
Biomab Ips S.A.S., Bogota, Colombia
A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 23
- Registration Number
- NCT05890105
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
🇺🇸Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19
- Conditions
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3000
- Registration Number
- NCT05890612
- Locations
- 🇰🇷
Pfizer Korea, Seoul, Korea, Republic of
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1142
- Registration Number
- NCT05886777
- Locations
- 🇺🇸
DM Clinical Research, Martin Diagnostic Clinic, Tomball, Texas, United States
🇺🇸West Coast Research, Dublin, California, United States
🇺🇸Marvel Clinical Research, Huntington Beach, California, United States
A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT05884554
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Research Centers of America ( Hollywood ), Hollywood, Florida, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.
- Conditions
- Interventions
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 48
- Registration Number
- NCT05879718
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸The Kirklin Clinic of UAB Hospital, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham - School of Medicine, Birmingham, Alabama, United States
Study of GBT021601 in Participants With Renal Impairment
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT05878704
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
🇺🇸Advanced Pharma CR, LLC, Miami, Florida, United States
🇺🇸Nucleus Network, Saint Paul, Minnesota, United States
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT05878522
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States